
IP Group
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
IP Group is an IP commercialization company specializing in evolving great ideas into world-changing businesses.
Investor Profile
IP Group has made 288 investments, with 4 in the past 12 months and 20% as lead.
Stage Focus
- Seed (41%)
- Series Unknown (22%)
- Series A (15%)
- Series B (11%)
- Series C (5%)
- Series D (2%)
- Pre Seed (1%)
- Undisclosed (1%)
- Series E (1%)
- Corporate Round (1%)
Country Focus
- United Kingdom (81%)
- United States (11%)
- Australia (2%)
- New Zealand (1%)
- Sweden (1%)
Industry Focus
- Biotechnology
- Software
- Health Care
- Information Technology
- Therapeutics
- Manufacturing
- Medical
- Health Diagnostics
- Analytics
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.